J
Jill P. Smith
Researcher at Geisinger Health System
Publications - 3
Citations - 2909
Jill P. Smith is an academic researcher from Geisinger Health System. The author has contributed to research in topics: Placebo-controlled study & Hepatitis C. The author has an hindex of 3, co-authored 3 publications receiving 2575 citations.
Papers
More filters
A Randomized Double-blind Placebo-controlled Trial
TL;DR: The purpose of the present investigation was to evaluate the safety and effectiveness of the antiviral drug amantadine for the treatment of hepatitis C in those who had either previously failed interferon therapy or were not candidates for interferons.
Journal ArticleDOI
Preventive Care in Chronic Liver Disease
Thomas Riley,Jill P. Smith +1 more
TL;DR: Based on the existing data, the preventive strategies of alcohol avoidance, hepatitis vaccination, avoidance of NSAIDs nonsteroidal anti-inflammatory drugs, iron supplementation when appropriate, and a low-fat diet are prudent in patients with chronic liver disease.
Amantadine therapy for chronic hepatitis C: A randomized double-blind placebo-controlled trial
TL;DR: Oral amantadine may provide a safe alternative treatment for those patients who are intolerant or unresponsive to interferon, and the social quality of life survey improved with 12 months of amanadine.